We read with interest the article by Leeds et al. ([@B1]) describing the prevalence of increased microvascular complications in patients with type 1 diabetes and newly diagnosed celiac disease (CD).

Leeds et al. stated that adults with type 1 diabetes and undetected CD have worse glycemic control with more renal disease and more retinopathy compared with patients with type 1 diabetes alone. The newly diagnosed CD patients in the cohort of type 1 diabetes patients are matched for age, duration of type 1 diabetes, and weight. We believe that one critical point by which the increased prevalence of microvascular complications in patients with CD and type 1 diabetes could be influenced is not taken into consideration. In type 1 diabetes, HbA~1c~ levels are an important predictor of the development of complications ([@B2]) and are a possible confounder in the prevalence of retinopathy and neuropathy. In the presented study of Leeds et al., the study group (CD and type 1 diabetes) and control group (type 1 diabetes only) have not been matched for HbA~1c~ levels. Therefore, it cannot be excluded that after matching case and control subjects for HbA~1c~ levels, a trend in the prevalence of these complications will not be found.

As many studies have investigated the prevalence of CD in adult type 1 diabetic patients ([@B3]) only few have studied this in the context of glycemic control. Until now, conflicting results have been published regarding glycemic control in adults with type 1 diabetes and undetected CD. Increased HbA~1c~ levels at diagnosis of CD have been observed previously ([@B4]), and similar findings are reported by Leeds et al. ([@B1]). Nevertheless, data are not uniform since decreased HbA~1c~ levels at CD diagnosis have been reported as well ([@B5]). The different outcomes of the studies might relate to factors such as small sample size, size of the control group, and a different matched control group.

Up until now, no clear consensus exists about the need for screening for CD in adult type 1 diabetic patients. Taken together, if indeed the prevalence of microvascular disease is higher in type 1 diabetic patients with newly detected CD, corrected for HbA~1c~ levels, this implicates that screening for CD in adults is mandatory.
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